The results of the trial align with earlier studies conducted in Europe, where UroShield improved patient outcomes.

Thanks to the expected introduction of several late-stage pipeline products. The type 1 diabetes (T1D) market across the ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...

A GlobalData survey shows 82% of Gen Z and 84% of Millennials thought ingredients helping relaxation or boosting mood were ...

Based on the data, China’s domestic market saw its second consecutive month of acceleration in November.

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

MET-3 is under development for the treatment of hypertriglyceridemia. It comprises live microbiota that normally reside in the human gut of a healthy individual. It is administered through oral route ...

ABI-110 is under clinical development by Avirmax and currently in Phase II for Polypoidal Choroidal Vasculopathy.